News and Trends 3 Oct 2022
Poxel granted orphan drug designation for kidney disease treatment
French biopharma company Poxel SA says the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to PXL770 for the treatment of patients with autosomal-dominant polycystic kidney…